On 23rd May, Moneylife wrote on how a Kerala citizen was denied access to Western Ghats Ecology Expert Panel Report (WGEEP). The Central Information Commission and the Delhi High Court ordered the ministry to make it public. It has now been uploaded on its site Just when one wondered whether the ministry of environment & forests (MoEF) would turn to the Supreme Court after the Delhi High Court on 17th May,...
More »SEARCH RESULT
TV plea on House panels
-The Telegraph Vice-President and Rajya Sabha chairman Hamid Ansari has suggested that meetings of parliamentary standing committees should be open to public or televised live, as in many western democracies. Such panels do “excellent work” but remain unsung, Ansari said as he made the proposal at a two-day orientation programme for new entrants to the Rajya Sabha that began yesterday. He said he had discussed the issue with MPs. But some of the...
More »Target of intolerance -Venkitesh Ramakrishnan
Religious and social groups have trampled on the freedom of expression of artists and scholars to serve their own agendas. “FOR all the big talk about India's great tradition of cultural and religious tolerance, many forces in the social life of our country and a number of established organisations, including the so-called non-political ones, have time and again resorted to blatant suppression of freedom of expression, pointing forcefully to the...
More »Censoring the Net -TK Rajalakshmi
The IT (Intermediaries Guidelines) Rules, drafted to protect intermediaries, now appear to be a tool that can be used to harass them. EIGHT years ago, the chief executive officer of an auction portal was put behind bars because a user put an obscene MMS clip up for sale on the site. This sparked a demand from intermediaries, the entities that provide services enabling the delivery of online content to end-users,...
More »Panel exposes flaws in India’s drug approval procedure-Vidya Krishnan
A report by a parliamentary committee has shown that the drug industry regulator, the Drug Controller General of India (DCGI), has been approving, on average, one new drug a month without conducting mandatory clinical trials or seeking expert medical opinion—findings that expose the deep flaws prevalent in India’s drug approval process. The committee has asked the health ministry to withdraw the discretionary powers given to the Central Drugs Standard Control Organization...
More »